Chronic Pruritus Clinical Trial
— PRURISINEOfficial title:
Causes of Chronic Pruritus: a Retrospective Study
Verified date | July 2021 |
Source | University Hospital, Brest |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this study is to include all patients followed between 2008 and 2018 in order to analyze the etiologie of the chronic pruritus
Status | Completed |
Enrollment | 200 |
Est. completion date | October 2, 2019 |
Est. primary completion date | October 2, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - more than 18 years old - In patient in a day hospital or longer hospitalization in the dermatology department - With chronic pruritus which means pruritus longer than 6 weeks without skin lesions specific to pruritic dermatitis. Exclusion Criteria: - Itchy dermatose - Refusal to particpate |
Country | Name | City | State |
---|---|---|---|
France | CHRU de Brest | Brest |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Causes of chronic pruritus | Analyze the etiology of chronic pruritus : uremic pruritus, cholestatic pruritus, haematologic pruritus, metabolic pruritus, neuropathic pruritus, psychogenic pruritus, idiopathic pruritus thanks to results of biological parameters, Imaging data, clinical data (for example consultation with psychiatric for psychogenic pruritus) | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05038982 -
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
|
Phase 2 | |
Completed |
NCT01951274 -
VPD-737 for Treatment of Chronic Pruritus
|
Phase 2 | |
Completed |
NCT02672579 -
Study of Kids Itch Severity (SKIS)
|
||
Completed |
NCT03751111 -
Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone
|
Phase 1/Phase 2 | |
Completed |
NCT04693195 -
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
|
Phase 2 | |
Not yet recruiting |
NCT05678309 -
Establishment of a Patient Library in Patients With Pruritus Sine Materia
|